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Abstract: Human milk provides immunoglobulins (Igs) that supplement the passive immune system
of neonates; however, the extent of survival of these Igs during gastric digestion and whether this
differs between preterm and term infants remains unknown. Human milk, and infant gastric samples
at 2 h post-ingestion were collected from 15 preterm (23–32 week gestational age (GA)) mother-infant
pairs and from 8 term (38–40 week of GA) mother-infant pairs within 7–98 days postnatal age.
Samples were analyzed via ELISA for concentration of total IgA (secretory IgA (SIgA)/IgA), total
secretory component (SC/SIgA/SIgM), total IgM (SIgM/IgM), and IgG as well as peptidomics. Total
IgA concentration decreased by 60% from human milk to the preterm infant stomach and decreased
by 48% in the term infant stomach. Total IgM and IgG concentrations decreased by 33% and 77%,
respectively, from human milk to the term infant stomach but were stable in the preterm infant
stomach. Release of peptides from all Ig isotypes in the term infant stomach was higher than in
the preterm stomach. Overall, the stability of human milk Igs during gastric digestion is higher
in preterm infant than in term infants, which could be beneficial for assisting the preterm infants’
immature immune system.
Keywords: passive immunity; antibodies; lactation; peptidomics; prematurity; proteolysis; breast milk
1. Introduction
Immunoglobulins (Igs) are important effectors of the adaptive immune system [1]. During the
third trimester, the mother’s placenta transports IgG to the fetus via a neonatal Fc receptor. These
maternal IgG antibodies protect the infant during the first 6 months of postnatal age while the infant’s
own immune system is developing [2]. After birth, human milk provides another form of protection
against pathogens for infants, as it contains an array of Igs, including IgA, secretory IgA (SIgA), IgM,
secretory IgM (SIgM), and IgG [3,4]. Indeed, feeding mother’s milk reduces risks of infectious diseases
in the respiratory and gastrointestinal tract in infancy [5]. Though human milk provides different Ig
isotypes, milk SIgA is thought to be the most important in the infant gut as it neutralizes bacterial
and viral pathogens by binding to them, thus reducing their ability to interact with epithelial cells
and infect [6,7]. The presence of SIgA in human milk temporarily replaces the normal intestinal SIgA
secretion that is lacking in the infant until 4 weeks of postnatal age [8].
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SIgA is the first line of defense in protecting the intestinal epithelium from pathogens by immune
exclusion [9]. Though SIgA is the most well-known and abundant Ig of intestinal secretions [10], IgG
and IgM are also secreted by plasma cells in neonatal intestinal mucosa [11,12]. IgG may have function
in the gut: passive administration of virus-neutralizing IgG prevented mucosal immunodeficiency
virus transmission from mother to infant in macaques [13], suggesting potential transmission of these
IgG in the gut. However, the ability of IgG to bind to viruses to prevent attachment to the mucosal
surface or trap pathogens in mucus appears to be inefficient compared with SIgA [13]. Human neonatal
Fc receptor (FcRn) may be able to transport IgG (alone or bound to an antigen) across the intestinal
epithelial barrier into the lamina propria [11]. Though IgM-secreting cells have been identified in the
infant gut [12] and IgM was shown to be synthesized in amounts similar to IgA in pig small intestinal
mucosal explants [14,15], no study has determined the extent to which IgM plays a role in the adult or
infant intestinal mucosal immune defense.
In order to function in immunoprotection in the gut, IgA and potentially the other Ig must resist
proteolytic degradation and remain intact and able to bind to pathogens through the digestive system.
Though the provision of milk Igs to the infant is known to reduce infection risk, the degree to which
Igs survive in the gastrointestinal tract remains unknown. Few studies have investigated the stability
of Igs in digestion. Two oral supplementation studies (in adults fed bovine colostrum SIgA/IgA, IgM
and IgG [16] and in preterm infants fed serum IgA and IgG [17]) demonstrated that IgG and IgM
survive intact to the stool, whereas SIgA/IgA does not. However, some studies have demonstrated
that human milk-derived SIgA survived intact to the infant stool and urine [8,18,19].
Our previous study demonstrated that preterm infants had lower gastric digestion capacity for
human milk proteins than term infants [20]. This difference in digestion capacity could affect the
survival of immunoglobulins. Our recent studies demonstrated that preterm infants partially degrade
IgA but not IgG and IgM in the stomach [21,22]. Whether differences in preterm and term infant
gastric digestion result in differences in Ig survival remain unknown. The aim of the present study
was to determine whether preterm infant Ig survival in the stomach is higher than in term infants.
As preterm infants are born early and miss some of the placenta-fetal IgG transfer [23], produce
less diverse of antibodies in their gut in comparison with term infants [24], and are at higher risk for
bacterial [25] and viral infections [26] than term infants, the presence of Ig in human milk may be even
more critically important to their health outcomes than for term infants. Therefore, milk-provided
Ig may be even more critically important than for term infants. Increased survival of milk Igs in the
preterm infant stomach due to lower protein digestion capacity could provide increased direct support
of their naïve immune systems through immune exclusion.
2. Materials and Methods
2.1. Participants and Sample Collection
This study was approved by the Institutional Review Board of the University of California, Davis
(UC Davis) and Oregon State University (OSU). Inclusion criteria included inpatient admission to the
neonatal intensive care unit (NICU), an indwelling nasogastric or orogastric feeding tube and tolerance
of full enteral feeding. Most of the enrolled infants required a feeding tube because of uncoordinated or
immature capacity to suck and swallow. Exclusion criteria were anatomic or functional gastrointestinal
disorders. Enrolled infants had a variety of medical conditions, including respiratory distress
syndrome, chronic lung disease, apnea of prematurity, and Dandy–Walker malformation in the
premature infants and cleft palate, respiratory distress syndrome, hypoxic-ischemic encephalopathy,
and congenital diaphragmatic hernia in the term infants, but no overt gastrointestinal tract issues.
Respiratory distress syndrome and congenital diaphragmatic hernia can delay gastric emptying in
preterm infants [27,28]; however, the other medical conditions in this cohort have not been associated
with an effect on gastric emptying or digestion capacity. Hypoxic-ischemic encephalopathy may result
in gastrointestinal tissue damage [29]; however, the effects on gastric emptying and protein digestion
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are unknown. The infants with hypoxic ischemic encephalopathy were fasted and underwent whole
body cooling for 72 h starting shortly after birth, however this treatment was completed and the infants
advanced to full enteral feeding prior to enrollment. The infant with congenital diaphragmatic hernia
had the defect repaired and was advanced to full enteral feeding prior to enrollment. Gastroesophageal
reflux is almost universal in this population; however, none of the infants sampled received medications
known to affect gastric pH or gastric digestion capacity, including prokinetics, H2 blockers/antagonists
or proton-pump inhibitors. The enrolled infants were clinically stable at the time of sample collection
(not on mechanical ventilation, stable vital signs). Samples were collected from 15 premature-delivering
mother-infant pairs ranging in gestational age (GA) at birth from 23 to 32 weeks and 8 term-delivering
mother-infant pairs ranging in GA at birth from 38 to 40 weeks (Table 1) over 7–98 days of postnatal age
at the UC Davis Children’s Hospital NICU in Sacramento, California. Enrolled infants had a variety of
medical conditions, but no overt gastrointestinal tract issues or other medical conditions that have been
associated with an effect on gastric emptying or digestion capacity. The enrolled infants were clinically
stable at the time of sample collection (not on mechanical ventilation, stable vital signs). Human milk
samples were collected as described in our previous study [30]. The preterm infants were fed their
mother’s milk (raw, not pasteurized) with fortifier (Similac Human Milk Fortifier Powder, Abbott
Park, IL). The powdered fortifier contained intact bovine milk proteins and its protein composition
was designed to match the whey:casein of human milk (60:40) using non-fat milk and whey protein
concentrate. Each 25 mL of human milk was fortified with 0.25 g of bovine milk proteins (adding 10 mg
protein/mL). Term infants were fed their mother’s milk (raw, not pasteurized) without fortification.
The human milk feedings were delivered via the nasogastric tubes over 30 min. Two hours after the
initiation of feeding, 2 mL of each preterm and term infant’s gastric contents were collected in a syringe
back through the feeding tube via suction as previously described in our studies [21]. Gastric samples
were aspirated at 2 h postprandial to obtain samples that represented a compromise between when
adequate sample remained recoverable from the stomach and a maximum feasible length of gastric
digestion time had passed based on gastric emptying times [31]. Human milk and gastric samples
were placed into sterile vials and stored at −20 ◦C and were transported to OSU on dry ice and stored
at −80 ◦C.
Table 1. Demographics of preterm- and term-delivering mother-infant pairs sampled for human milk
and gastric contents at 2 h postprandial.
Demographics Preterm-Delivering Mother Infant Pairs 1–2 Term-Delivering Mother-Infant Pairs 1–2
GA, weeks 27 ± 3 (23−32) 38.9 ± 0.5 (38−40)
Postnatal age, day 39 ± 28 (7−98) 23 ± 11 (16−42)
Postmenstrual age, day 32 ± 2 (30−37) 42 ± 2 (41−45)
Birth weight, kg 1.0 ± 0.4 (0.5−1.6) 3.5 ± 0.3 (3.0−3.8)
Infant sex 13 females; 2 males 6 females; 2 males
Mother’s age, year 35 ± 3 (32−39) 24 ± 10 (17−42)
1 Values are mean ± SD (range); 2 Number of paired milk and gastric samples from preterm and term infants is
n = 15 and n = 8, respectively.
2.2. Sample Reparation and ELISAs
Samples were thawed at 4 ◦C, pH was determined, and samples were centrifuged at 4226× g for
10 min at 4 ◦C. The infranate was collected, separated into aliquots and stored at −80 ◦C. The pH of
the samples was measured with an S220 SevenCompact pH/Ion meter (Mettler-Toledo, Columbus,
OH, USA) equipped with a combined sealed glass electrode.
The spectrophotometric ELISAs were recorded with a microplate reader (Spectramax M2,
Molecular Devices, Sunnyvale, CA, USA) with two replicates of blanks, standards, and samples.
SoftMax Pro 7.0 Microplate Data Analysis Software (Molecular Devices) was used to create a standard
curve with a Four Parameters Logistic curve fit. ELISAs were performed according to the methods
described by the manufacturers with some modifications as described (Table S1). The specific
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Ig concentrations in the samples were determined with antibody specificities as follows: human
anti-alpha-chain antibody for total IgA (SIgA/IgA), anti-SC antibody for total SC (SC/SIgA/SIgM),
gamma-chain antibody for IgG and mu-chain antibody for total IgM (SIgM/IgM). Concentrations of
total IgA, total SC, total IgM and IgG were determined in human milk and gastric samples as well as
in the fortifier alone.
For a separate test of the effect of the gastric pH change on Igs, ELISA were performed on standard
Igs (total IgA, total SC, total IgM and IgG) in milk before and after incubation at pH 4.5 for 1 h at 37 ◦C.
HCl (10 mM) was used to adjust the pH to 4.5.
2.3. Peptidomic Analysis
Peptide extraction from human milk and gastric samples was performed as described
previously [32]. Mass spectrometric parameters were as described previously [33]. Spectra were
analyzed by database searching in Thermo Proteome Discoverer (v2.1.0.81) using an in-house human
milk protein sequence database. The tandem spectra were used to determine the counts and abundance
of Ig alpha-chain (from IgA or SIgA), Ig gamma-chain (from IgG), Ig mu-chain (from IgM or SIgM),
Ig J-chain (from IgA, SIgA, IgM or SIgM), Ig kappa-chain and Ig lambda-chain (from IgA, SIgA,
IgM, SIgM or IgG), SC (f19–603 of total polymeric immunoglobulin receptor (PIgR)), and neonatal Fc
receptors (FcRn). Only peptides identified with high confidence (p < 0.01) were included, and peptide
sequences with multiple modifications were grouped into a single peptide for counts. Peptide counts
measured the number of unique peptides identified in a sample whereas peptide abundance measured
the ion intensity of the peak in a sample.
2.4. Statistical Analyses
Wilcoxon matched-pairs signed-rank test for paired sample comparisons (across milk and
gastric samples within the same infant) and Mann–Whitney tests for unpaired sample comparisons
(preterm versus term infants) were applied using GraphPad Prism software (version 7.03). All tests
were nonparametric as some of the values did not pass the D ’Agostino & Pearson normality test.
Linear regression models were applied to determine if the concentrations of total IgA, total SC, total
IgM and IgG in human milk and in gastric samples in both infant groups changed across postnatal
age, GA, postmenstrual age (PMA), body weight at birth (BWb), body weight at sampling (BWs), and
feed volume. Differences were designated significant at p < 0.05. Pearson correlation coefficients (r)
were determined when p < 0.1. The sample size of preterm (n = 15) and term (n = 8) paired milk and
gastric samples was selected based on our previous study [20] and proved to be adequately powered
to detect differences based on the results.
3. Results
3.1. Infant Demographics
Demographic details for the preterm- and term-delivering mother–infant pairs are presented in
Table 1.
3.2. Ig Concentrations
3.2.1. Total IgA Concentration
Total IgA (SIgA/IgA) concentration decreased 60% (p = 0.001, Figure 1A) from human milk
to the preterm infant stomach, and 47.8% from human milk to the term infant stomach (p = 0.016,
Figure 1B). Total IgA concentration was similar between preterm and term milks and between preterm
and term gastric contents (p > 0.05, Table S2). Total IgA concentration in preterm milk and gastric
samples decreased with increased postnatal age, PMA, and BWs (p < 0.05) but did not change in term
samples (p > 0.05) (Table S3). Total IgA concentration in human milk or gastric contents did not change
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across GA and feed volume within preterm and term infants (p > 0.05, Table S3). When human milk
was incubated under in vitro acidic conditions (pH 4.5) to match stomach conditions but without the
proteases, there was no decrease in IgA concentration. No IgA was detected in the fortifier.
3.2.2. Total SC Concentration
Human milk total SC (SC/SIgA/SIgM) concentration significantly decreased 62% (p = 0.031,
Figure 1D) from human milk to the term stomach but did not change in the preterm infant stomach
(p = 0.33, Figure 1C). Total SC concentration did not differ between human milk from preterm- and
term-delivering mothers (p = 0.22), nor between preterm and term gastric contents (p = 0.11). Total
SC concentration in milk and gastric samples in term and preterm infants did not change across GA,
postnatal age, or PMA (p > 0.05, Table S3). No total SC was detected in the fortifier.
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Total IgM (SIgM/IgM) concentr tion decreased si nificantly (p = 0.016, Figure 2B) 33% from
human milk to the term infant stomach but did not change in th preter infant stomach (p = 0.54,
Figure 2A). Total IgM concentratio in human milk from preterm-delivering mothers was 77% lower
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than in milks from term-delivering mothers (p < 0.001, Figure S1A) but did not differ in the gastric
contents between preterm and term infants (p = 0.56). Total IgM concentration in either milk or gastric
samples did not change across postnatal age, GA, PMA, or BWb for term or preterm infants (p > 0.05,
Table S3). Total IgM concentration decreased in preterm milk with increasing postnatal age or BWs
(p < 0.05) but did not change in term milk or in either preterm or term stomach samples (p > 0.05,
Table S3). Total IgM concentration increased with increasing feed volume in preterm milk and gastric
samples but did not change in term samples. No total IgM was detected in the fortifier.
Nutrients 2018, 10, x FOR PEER REVIEW  6 of 13 
 
samples did not change across postnatal age, GA, PMA, or BWb for term or preterm infants (p > 0.05, 
Table S3). Total IgM concentration decreased in preterm milk with increasing postnatal age or BWs 
(p < 0.05) but did not change in term milk or in either preterm or term stomach samples (p > 0.05, 
Table S3). Total IgM concentration increased with increasing feed volume in preterm milk and gastric 
samples but did not change in term samples. o total IgM was detected in the fortifier. 
 
Figure 2. Immunoglobulin concentrations in human milk and gastric samples at 2 h postprandial time 
from paired mother-infant delivered prematurely (23–32 week of gestational age (GA), 7–98 days of 
postnatal age) and at term (38–40 week of GA, 16–42 days of postnatal age). Concentration of total 
IgM (SIgM/IgM) (A) in preterm infant samples and (B) in term infant samples; Concentration of IgG 
(C) in preterm infant samples and (D) in term infant samples. Values are mean ± SEM, n = 15 for 
preterm infants and n = 8 for term infants. Asterisks show statistical significant differences between 
variables (*** p < 0.001; * p < 0.05) using the Wilcoxon matched-pairs signed-rank test. 
3.2.4. IgG Concentration 
IgG concentration decreased significantly (48%, p = 0.026, Figure 2D) from human milk to the 
term infant stomach but did not change in the preterm infant stomach (p = 0.11, Figure 2C). IgG 
concentration in human milk from preterm-delivering mothers was 97% lower than in milks from 
term-delivering mothers (p < 0.001, Figure S1B) but did not differ in the gastric contents between 
preterm and term infants (p = 0.58). IgG concentration in preterm and term milk did not change across 
postnatal age, GA, PMA, BWb, or feed volume (p > 0.05, Table S3). IgG concentration in preterm 
gastric samples decreased with increasing PMA or BWs and increased with increasing BWb in term 
stomach but did not change across GA or feed volume. No IgG was detected in the fortifier. 
  
Figure 2. Immunoglobulin concentrations in human milk and gastric samples at 2 h postprandial time
from paired mother-infant delivered prematurely (23–32 week of gestational age (GA), 7–98 days of
postnatal ge) and t term (38–40 week of GA, 16–42 days of postnatal age). Conce tr ti f t tal IgM
(SIgM/IgM) (A) in preterm infant samples and (B) in term infant samples; Concentration of IgG (C) in
preterm i fan samples and (D) in term i fant sample . Va ues are mean ± SEM, n = 15 for preterm
infants and n = 8 for term infants. Asterisks show statistical significant differences between variables
(*** p < 0.001; * p < 0.05) using the Wilcoxon matched-pairs signed-rank test.
3.2.4. IgG Concentration
IgG concentration decreased significantly (48%, p = 0.026, Figure 2D) from human milk to the
term infa t stomach but did not change in the preter infant stomach (p = 0.11, Figure 2C). IgG
concentration in hu an milk from preterm-delivering m hers was 97% lower tha in milks from
term-d liveri g mothers (p < 0.001, Figure S1B) but did not differ in the gastric ontents between
preterm and term infants (p = 0.58). IgG concentration in preterm and term milk did not change across
postnatal age, GA, PMA, BWb, or feed volume (p > 0.05, Table S3). IgG concentration in preterm gastric
samples decreased with increasing PMA or BWs and increased with increasing BWb in term stomach
but did not change across GA or feed volume. No IgG was detected in the fortifier.
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3.3. Peptidomic Results
No peptides (counts or abundance) for Ig alpha-chain, Ig gamma-chain, Ig mu-chain, Ig J-chain,
Ig lambda-chain, and Ig kappa-chain were detected in human milk from either the mothers who
delivered prematurely or at term, but peptides from each of these proteins appeared in the gastric
samples from both preterm and term infants (Figures S2–S4). Peptides from SC (f19–603 of PIgR) was
detected in both milk and gastric samples from both preterm and term infants.
Ig alpha-chain peptide counts in gastric samples were 1.2-fold lower in preterm infants than in
term infants (not significant, but a tendency: p = 0.081, Figure 3A). Ig alpha-chain peptide abundance
in gastric contents was 16-fold lower in preterm infants than in term infants (p = 0.038, Figure 3D).
Ig mu-chain peptide counts and abundance in gastric contents were 2.3- (p = 0.032, Figure 3B) and
13-fold (p = 0.010, Figure 3E), respectively, lower in preterm infants than in term infants. Ig gamma-chain
peptide counts and abundance in gastric contents were 1.9- (p = 0.002, Figure 3C) and 34-fold (p < 0.001,
Figure 3F), respectively, lower in preterm infants than in term infants. Peptide counts and abundance of
Ig J-chain, lambda-chain and Ig kappa-chain did not differ between preterm and term infant gastric
samples (p > 0.05, Table S2). Peptide counts of SC (f19–603 of PIgR) decreased 37% and 56% from
human milk to the stomach for preterm and term infants, respectively (p < 0.05, Figure 4A,B). Peptide
abundance of SC decreased 89% and 68% from human milk to the stomach for preterm and term infants,
respectively (p < 0.05, Figure 4C,D).
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Figure 3. Peptide counts and abundance of human immunoglobulin fragments in human milk and
gastric samples at 2 h postprandial time from paired mother-infant delivered prematurely (23–32 week
of gestational age (GA), 7–98 days of postnatal age) and at term (38–40 week of GA, 16–42 days
of postnatal age). (A,D) Ig alpha-chain (from SIgA/IgA) and (B,E) Ig mu-chain (from SIgM/IgM);
(C,F) Ig gamma-chain (from IgG). Values are mean± SEM, n = 15 for preterm infants and n = 8 for term
infants. Asterisks show statistical significant differences between variables (*** p < 0.001; ** p < 0.01;
* p < 0.05) using the Mann–Whitney test (unpaired samples).
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Concentrations of Igs in human milk from mothers delivering prematurely and at term were 
congruent with those found in previous studies [36,37,40,41]. Concentrations of total IgA or total SC 
Figure 4. Peptides counts and abundance of SC (f19–603 of PIgR) in human milk and gastric samples
from mother–infant pairs with preterm delivery (23–32 week of gestational age (GA), 7–98 days of
postnatal ge) and term delivery (38–40 e f , 16–42 days of postnatal ag . Peptides counts of
SC (A) in preterm infant samples; (B) in ter t samples. Peptide abundance of SC (C) in preterm
infant s mples and (D) in term infant samples. l re ean ± SEM, n = 15 for preterm infants and
n = 8 for term infants. Asterisks show statistical significant differences between variables (** p < 0.01;
* p < 0.05) using the Wilcoxon matched-pairs signed-rank test.
3.4. pH
For preterm and term mother-infant samples, pH values in gastric samples were lower than those
in human ilk (p < 0.001, Figure S5). Neither milk nor gastric sample pH differed between preterm
and term mother-infant pairs (p > 0.05, Table S2).
4. Discussion
The Ig concentrations in milk from preterm- and term-delivering ot ers have been previously
studied [34–37]. No study has compared the survival of Igs in the stomach or intestine between
preterm and term infants. Our recent studies demonstrated that preterm infants partially degrade IgA
but not IgG and IgM in the stomach [21,22]. A few studies have measured the survival of milk Igs to
infant stool [17,38]. However, measuring Igs in infant stool samples does not accurately represent the
biologically relevant survival of Igs within the upper GI tract, as Igs are exposed to proteases from the
infant gastrointestinal tract as well as protein-fermenting colonic bacteria, which can degrade them
before they are identified in stool [39]. To begin to addre s this lack of knowledge, the prese t study
examined the stabil ty of human milk Igs—total IgA (SIgA/IgA), total IgM (SIgM/IgM), IgG, and total
SC (SC/SIgA/SIgM)—during gastric digestion in preterm and term infants.
Concentrations of Igs in human milk from mothers delivering prematurely and at term were
congruent with those found in previous studies [36,37,40,41]. Concentrations of total IgA or total SC
did not differ between preterm and term milk, which matches with the observation in a previous
study [34] that milk total IgA did not differ between preterm and term milk (3.2 mg/mL) from 6 to
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28 days postnatal age. Ballabio et al. [34] observed a higher concentration of total IgA than measured
in this present study and did not detect IgM or IgG in preterm and term milk (we detected IgM and
IgG). This difference could be due to their use of an immunoelectrophoretic technique (SDS-PAGE
and immunoblotting) to determine the concentration of Igs in their milk samples. ELISA is more
quantitative (lower detection limit) than SDS-PAGE and immunoblotting. We found that total IgA
concentration decreased with increasing postnatal age, PMA, and BWs in preterm milk, which matches
with this same previous study [34] (total IgA concentration decreased from colostrum to mature milk
from preterm-delivering mothers). A few studies found higher amounts of total IgA in colostrum
from preterm-delivering mothers compared with colostrum from term-delivering mothers [3,34,35,42];
however, as no colostrum was collected in the present study, we cannot compare our results to that
data. Another study found that preterm milk IgA concentration was 1.1- to 1.4-fold higher than in
term milk from 3 to 15 days but found no differences in concentration from 28 to 56 days of postnatal
age [3]. Thus, the observed lack of difference for total IgA concentration between preterm and term
milk in the present study is likely due to the older postnatal age (average: 39 days for preterm and
23 days for term infants) for milk collection.
The concentration of total SC (mostly SIgA but can include SC and SIgM) represented 73.5% of
total IgA in preterm milk and 63.6% of total IgA in term milk. These percentages are somewhat lower
than the observations reported by Goldman et al. [4] that total SC (called “SIgA” by the authors but
actually representing total SC, as an anti-SC primary antibody was used) concentration represented
90% of the total IgA in term milk.
The concentration of IgG and total IgM were lower in human milk from preterm-delivering
mothers than term-delivering mothers. Previous studies observed IgG and IgM concentrations in
human milk that were similar between mothers delivering prematurely and at term [36,41]. On the
other hand, Chandra et al. [3] found that IgM and IgG concentrations were 1.5-fold higher in preterm
milk than in term milk from 14 to 28 days of postnatal age.
The total IgA concentration decreased from human milk to the preterm and term infant stomach.
The stability of SC/SIgA/SIgM during gastric digestion in preterm suggests that SC remains intact
and detectable by the anti-SC even if it is released from the SIgA complex. Unlike in preterm infant,
total SC concentration decreased in the term infant stomach. The reduction of total IgA (SIgA/IgA)
was likely due to degradation by proteases (pepsin and/or milk proteases [21]) and not acid-induced
structural deterioration in the stomach, as incubation of standard IgA in acid conditions did not
decrease its concentration (Figure S6). If we consider that 74% of total IgA in preterm milk is SIgA—we
could not distinguish between SC/SIgA/SIgM, the decrease of total IgA likely derived from preterm
gastric digestion of partly IgA and partly SIgA. We found higher peptide abundance of Ig alpha-chain
(which could derive from either IgA or SIgA) in term infant gastric contents than in preterm infants,
which suggests that IgA/SIgA is more digested by term infants than preterm infants.
We also observed that human milk total IgM decreased and IgG tended to decrease in the term
stomach (48% and 49% reduction, respectively) but were stable in the preterm stomach. We found
higher peptide counts and abundance of Ig mu (which could derive from either IgM or SIgM) and Ig
gamma (which derive from IgG) in term infant gastric infants than preterm infants, which suggests
that SIgM/IgM and IgG is more digested by term infants than preterm infants. This decrease of Igs is
unlikely to relate to gastric pH as preterm and term infants’ gastric pH did not differ. We also observed
that pH 4.5 had no effect on the stability of Igs (Figure S2). Gastric proteases are likely responsible for
observed differences, as we previously demonstrated that gastric pepsin activity and proteolysis were
higher in term infants than in preterm infants [20].
We observed that the stability of IgG and total IgM during gastric preterm digestion was higher
than total IgA. No previous study evaluated the digestibility of Igs in the preterm or term infant
stomach or small intestine, but a previous study [17] found a greater reduction of IgA compared with
IgG or IgM in preterm infant stools. When preterm infants (1–28 days of postnatal age (GA unknown)
0.8–2 kg BW) were fed only infant formula or infant formula plus pasteurized pooled human milk
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supplemented with 600 mg daily of serum-derived human IgA (73%) and IgG (26%), the stool samples
collected contained 1–10 mg IgG per g of dried feces (percentage reduction not calculated) and no
IgA [17]. We showed that IgG was decreased in the term infant stomach but stable in the preterm
infant stomach.
Using peptidomics, we demonstrated partial digestion (demonstrated by an increase in
peptide counts and abundances from milk to the stomach) of Ig alpha-chain (from IgA and SIgA),
Ig gamma-chain (from IgG), Ig mu-chain (from IgM or SIgM), and Ig J-chain (from IgA, SIgA, IgM
or SIgM), Ig kappa-chain and Ig lambda-chain (from all Igs) in both preterm and term infants.
Dallas et al. [43] also observed that alpha-1-chain (named IGHA1) was not detected in term milk
but was detected in the term stomach. SC peptide counts decreased in both preterm and term gastric
samples, suggesting that SIgA or SIgM were partially digested in the stomach from both infants.
We found a decrease in peptide counts and abundance of SC (which could derive from either SIgA
or SIgM) in both preterm and term infant gastric samples, suggesting a digestion of these Igs in the
infant stomach.
A limitation of this study is the small number of samples for preterm and term infants. Another
limitation is that we did not measure Ig concentrations in the infant intestine contents. Therefore, we
plan to examine how human milk Ig concentrations change in the stomach and intestine in a future
study with a larger number of preterm and term infants. The infants in our study had conditions that
required a naso-gastric tube, which could affect Ig digestion. However, we included only infants with
conditions that are not expected to interfere with protein digestion. Ideally, the study would include
healthier infants; however, placing a feeding tube in infants that do not require them is very challenging
from an ethical and patient enrollment perspective. Development of non-invasive techniques to collect
digestive samples from fragile infants would be highly beneficial to this field. The placement of the
nasogastric tube in these infants could also modify the gastric microbiome, which could influence Ig
digestion. However, as we currently have no technique to assess gastric digestion in infants without a
feeding tube, we cannot assess this potential impact.
5. Conclusions
The present study revealed that total IgA (SIgA/IgA) was digested in the preterm and term infant
stomach. Human milk total SC (SC/SIgA/SIgM), IgM, and IgG were stable in the preterm stomach but
were digested in the term stomach. Ig-derived peptides from all different Ig isotypes were in higher
amounts in the gastric contents of term infants than in preterm infants, demonstrating a higher overall
gastric Ig digestion in term infants. Therefore, human milk Igs are less digested in the preterm infant
stomach than the term infant stomach. As the stomach represents only the beginning of the digestive
system, the concentrations of human milk Igs in intestinal samples from preterm and term infants need
to be determined to clarify their potential survival during infant digestion. The longer that milk Igs
survive through the digestive system, the longer they can act as passive immune system components,
which is particularly important in the context of the immune system immaturity of the early postnatal
period in preterm and term infants.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/5/631/s1,
Table S1: Details for the assays performed in human milk and gastric samples; Table S2: Statistical results (p-values)
for Wilcoxon matched-pairs signed rank test to compare immunoglobulin concentrations (ELISA) and peptides
(peptidomics) in human milk and gastric samples in preterm and term infants (PM vs. PG or TM vs. TG); Table S3:
Statistical results (p-value) from the linear regression of the pH and the concentration of total IgA (SIgA/IgA),
total SC (SC/SIgA/SIgM), IgG and total IgM (SIgM/IgM) across postnatal age (P), gestational age at birth (GA),
postmenstrual age (PMA), BWb, BWs and feed volume (FV) in human milk and in gastric contents at 1, 2 and 3 h
postprandial from preterm infants (23–32 week of gestational age, 7–98 days of postnatal age) and term infants
(38–40 week of GA, 16–42 days of postnatal age); Figure S1: Immunoglobulin concentrations of (A) total IgM
(SIgM/IgM) and (B) IgG in mother’s milks delivering prematurely (23–32 week of gestational age (GA), 7–98 days
of postnatal age) and at term (38–40 week of GA, 16–42 days of postnatal age). Figures S2–S4: Peptide counts and
abundance of human immunoglobulin fragments in human milk and gastric samples at 2 h postprandial time
from paired mother-infant delivered prematurely (23–32 week of gestational age (GA), 7–98 days of postnatal
age) and at term (38–40 week of GA, 16–42 days of postnatal age). Figure S5: The pH in human milk and gastric
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samples in human milk and gastric samples at 2 h postprandial time from paired (A) mother-infant delivered
prematurely (23–32 week of gestational age (GA), 7–98 days of postnatal age) and (B) at term (38–40 week of
GA, 16–42 days of postnatal age). Figure S6: Stability of standard immunoglobulins (Igs) before and after the
incubation at pH 4.5.
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